Robert H. Uhl

Corporate Officer/Principal at

Westwicke Partners LLC

Health Technology

Finance

Profile

Robert H.
Uhl is currently the Managing Director at Westwicke Partners LLC, a position held since 2011.
Formerly, Mr. Uhl was Director-Investor Relations at Halozyme Therapeutics, Inc. in 2010 and served as Investor Relations Contact at DMK Pharmaceuticals Corp.

Robert H. Uhl active positions

Companies	Position	Start
Westwicke Partners LLC Westwicke Partners LLC Investment ManagersFinance Provides investment advisory and management consulting services	Corporate Officer/Principal	01/01/2011

All active positions of Robert H. Uhl

Former positions of Robert H. Uhl

Companies	Position	End
DMK PHARMACEUTICALS CORPORATION	Investor Relations Contact	-
HALOZYME THERAPEUTICS, INC.	Investor Relations Contact	-

See the detail of Robert H. Uhl's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Robert H. Uhl's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Halozyme Therapeutics, Inc. Halozyme Therapeutics, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of recombinant human enzymes for the infertility, ophthalmology & oncology markets	Health Technology
DMK Pharmaceuticals Corp. DMK Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for treatment of opioid overdose and substance-use disorders	Health Technology
Westwicke Partners LLC Westwicke Partners LLC Investment ManagersFinance Provides investment advisory and management consulting services	Finance